More than 64% of the adult women in the United States are overweight or obese, and these patients pose special challenges for surgeons. New research examining outcomes and complication rates, particularly in the emerging field of robotic surgery, will allow better management of these patients, and ObGyn.net will be paying special attention to this research at AAGL 2012 in Las Vegas.
More than 64% of the adult women in the United States are overweight or obese, and these patients pose special challenges for the laparoscopic surgeon. New research examining outcomes and complication rates, particularly in the emerging field of robotic surgery, will allow better management of these patients, and ObGyn.net will be paying special attention to this research at AAGL 2012 in Las Vegas.
Here’s a look at some of the research will be reporting on:
Wednesday, November 7, 2012: Laparoscopy Plenary
Hysterectomy Complications Among Overweight and Obese Women: The Role of the 95% Confidence Interval (Bernhard KA et al)
Wednesday, November 7, 2012: Open Communications, Research
Comparison of Perioperative Outcomes of Total Robotically Assisted, Laparoscopic and Open Hysterectomy Cases in Obese Patient Population (Tapisiz OL et al)
Wednesday, November 7, 2012: Plenary, Robotics
Surgical Outcomes of Morbidly Obese Patients in Treatment of Endometrial Cancer. Comparative Analysis of Robotic Surgery Versus Laparoscopic Surgery. (Lim PC et al)
Thursday, November 8, 2012: Surgical Tutorial
Handling the Laparoscopic and Robotic Problems in the Obese Surgical Patient
Friday, November 9, 2012: Open Communication, Advanced Endoscopy
Postoperative Complications of Obese Women after Hysterectomy: Comparing Laparoscopic, Vaginal and Abdominal Approaches (Ghanimati S et al)
HP-hMG stimulation reduces OHSS risk in high responder patients
October 25th 2024A recent study found that highly purified human menotropin significantly lowers the risk of ovarian hyperstimulation syndrome compared to recombinant follicle stimulating hormone, highlighting the benefits of protocol individualization based on gonadotropin type.
Read More